Adverse events after BNT162b2 do not differ for cancer patients
Feb 08, 2022
Among patients with cancer, pain at the injection site was less likely after dose 1 for those receiving active treatment.
NVX-CoV2373 vaccine protects against COVID-19
Dec 27, 2021
A study conducted in the U.S. and Mexico shows that the vaccine is 90% effective overall and 100% effective against moderate-to-severe disease.
No sign Supreme Court will block COVID-19 vaccination mandates, legal expert say
By
Kathleen Steele Gaivin
Dec 15, 2021
The U.S. Supreme Court declined Monday in a 6-3 ruling to hear a challenge to New York’s vaccine mandate for healthcare workers on religious grounds, and a legal expert says evidence is mounting that...
Rates of COVID-19, severe illness lower with BNT162b2 booster dose
Dec 09, 2021
A second study shows a reduction in the rate of death due to COVID-19 with a booster dose of BNT162b2 (Pfizer–BioNTech).
Federal judge rejects Florida AG’s case to block vaccination rule for healthcare workers
By
Kathleen Steele Gaivin
Nov 23, 2021
U.S. District Judge M. Casey Rodgers on Saturday denied a motion by Florida Attorney General Ashley Moody asking for a preliminary injunction or temporary restraining order against the Centers for Medicare...
30 percent of hospital-based healthcare personnel unvaccinated
Nov 22, 2021
Vaccination coverage was highest among HCP in children’s hospitals, followed by those in short-term acute care hospitals, long-term acute care hospitals, and critical access hospitals (77, 70.1,...
Florida lawmakers take on federal COVID-19 vaccination mandates
By
Kimberly Bonvissuto
Nov 19, 2021
A series of state bills aimed at dismantling employer COVID-19 vaccine mandates is headed to Florida Gov. Ron DeSantis’ desk, potentially making the state the first to fine employers for requiring vaccinations.
ACR: Lupus patients can have low immune response to COVID-19 vaccines
Nov 15, 2021
Overall disease activity does not appear to change after vaccination, however.
No change found in pattern of adverse events after third COVID-19 shot
Sep 30, 2021
Of the 12,591 individuals who completed a health check-in for all three doses, 79.4 and 74.1% reported local or systemic reactions, respectively.
mRNA-1273 continues to be efficacious at five months
Sep 27, 2021
The efficacy of mRNA-1273, the Moderna vaccine, was 93.2% for preventing COVID-19 illness and 98.2% for preventing severe COVID-19.